Search for: "IN RE WYETH"
Results 401 - 420
of 702
Sorted by Relevance
|
Sort by Date
1 Mar 2013, 2:30 pm
We’ve been pondering what to do with the latest 70+ page whopper from the Philadelphia Court of Common Pleas for a couple of weeks. [read post]
29 Nov 2007, 7:45 am
But why are we making such a big deal of these briefs, you might ask (especially if you're not a litigator). [read post]
20 Jan 2011, 12:50 pm
July 3, 2003); Wyeth-Ayerst Laboratories Co. v. [read post]
3 Jul 2008, 7:26 pm
Wyeth-Ayerst Laboratories, Division of Amer [read post]
7 Aug 2012, 4:10 am
Wyeth. [read post]
14 Mar 2008, 6:07 am
Wyeth-Ayerst Laboratories Co., the court encountered the redoubtable (we would say, very doubtable) Dr. [read post]
7 Jan 2015, 6:54 am
We’re going to miss it. [read post]
17 Nov 2015, 5:00 am
Not quite two years ago, we posted about how, under Wyeth v. [read post]
31 Jan 2014, 2:00 pm
Wyeth Pharmaceuticals, Inc., 737 F.3d 378, 397 (6th Cir. 2013) (Tennessee would not apply consumer expectation test to drugs).In our prior “bullseye” post we praised In re Fosamax Products Liability Litigation, ___ F. [read post]
13 May 2016, 10:10 am
Wyeth, LLC, 2016 WL 1719550 (N.D. [read post]
21 Jan 2016, 12:50 pm
Wyeth Laboratories Inc., 734 A.2d 1245, 1247, 1256 (N.J. 1999). [read post]
14 Oct 2013, 10:22 am
Frankly, if you’re in an office in just about any town other than New York City, “you lose that battle, you lose that battle nine times out of ten. [read post]
25 Jul 2013, 5:00 am
This guidance categorizes six different types of changes, with the category we’re discussing – labeling – on pages 24-26. [read post]
11 Apr 2013, 8:42 am
Wyeth Inc., No. 09-6168, slip op. [read post]
16 Apr 2013, 6:51 am
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004)), and the plaintiffs played the same non-severability card. [read post]
7 Aug 2014, 5:00 am
We’re still appalled. [read post]
16 Jan 2014, 7:31 pm
For the patents as to which it did not timely file suit under § 154(b)(4), it was only Novartis’s failure to comply with reasonable filing deadlines that prevented it from securing any patent term adjustment authorized by Wyeth. [read post]
30 Apr 2014, 10:11 am
Thanks to Terry Henryat Blank Rome for sending along today’s preemption decision in In re Fosamax (Alendronate Sodium) Products Liability Litigation (No. [read post]
20 May 2013, 7:03 am
Gee, if you’ve spent millions developing a drug and you’re given license to appraise its effectiveness and safety, wouldn’t you make sure the story had a happy ending? [read post]
20 Jun 2013, 5:00 am
That’s a long way from the sweeping presumption language in Wyeth v. [read post]
